Getting Medication – Government Statement

The Department of Health & Social Care have published a policy paper on access to medicines in the UK – including information about contingency plans for a ‘No Deal Brexit’. DHSC 18/01/2019 The government is working with pharmaceutical companies, suppliers, and the NHS to make sure patients continue to receive the medication they need if the UK leaves Continue Reading »

UKMi Q&A via SPS – New Resources

UKMi publish a series of Q&A documents on the NHS SPS website, with summaries of high quality, evidence-based, and quality controlled answers to common or unusual Medicines Information enquiries. The latest batch of seven new or updated Q&As was published in December: Which medicines require extra care when switching between liquid and tablet/capsule formulations? Information on medicines which require Continue Reading »

SPS Resources – UKMi Q&A documents

The UK Medicines Infomation network publish a series of Question & Answer documents via the NHS Specialist Pharmacy Service website. The Q&As are a response to demand for accessible summaries of high quality, evidence-based, and quality controlled answers to common or unusual enquiries made to Medicines Information services. A full list of current UKMi Q&As  can be found here, Continue Reading »

Aldosterone Antagonist Monitoring: Room for Improvement in UK Primary Care

NICE recommend offering or considering the addition of an aldosterone antagonist (AA), such as spironolactone and eplerenone, to treatment with an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker (ACEI/ARB) for management of treatment-resistant heart failure or hypertension and for patients who have had an acute MI and who have symptoms and/or signs of heart failure and left ventricular systolic dysfunction. Continue Reading »